In short
- Garman sold over $2.2 million in products, mostly unapproved and misbranded drugs, through Body Science Supplements.
- He used multiple bank accounts and wire transfers to move proceeds from these sales into personal and business accounts.
What happened
Skyler Garman, owner of Body Science Supplements, was sentenced to one year probation and ordered to forfeit $180,000 after admitting to distributing misbranded drugs and conspiring to commit money laundering. He sold SARMs and SERMs, which were unapproved and misbranded, using false labeling and provided dosing advice to customers.
Garman used several bank accounts to handle proceeds from sales, executing wire transfers to personal and business accounts. The products, sold online and shipped via mail and carriers, generated over $2.2 million, with the majority being unapproved and misbranded drugs.
This case demonstrates the risks posed when individuals illegally distribute misbranded drugs that have not undergone the rigorous FDA review process. With our partners, we will continue to hold accountable those who circumvent federal drug safety laws for financial gain.
In numbers
- $180,000 forfeited proceeds from offenses
- $2.2 million total product sales
Named in this item
Organization, regulator US — —
What compliance teams should check
- Review transactions involving Body Science Supplements and associated brands like 'Savior Research Sarms' and 'Savior Research Serms' for signs of misbranded drug sales.
- Monitor wire transfers and account activity linked to Garman and his associate for patterns consistent with money laundering described in the DOJ release.
- Check for products labeled 'not for human consumption' and verify if they are SARMs or SERMs, as these were used to mislead customers and circumvent FDA regulations.
Why it matters
This case highlights the risks of unapproved and misbranded drugs entering the market through supplement stores and online sales, often accompanied by misleading labeling and advice. Compliance officers must be vigilant for typologies involving multiple bank accounts, wire transfers, and false product labeling, as these are used to disguise proceeds and evade regulatory scrutiny. The enforcement action underscores the importance of monitoring for violations of the Federal Food, Drug, and Cosmetic Act and related money laundering activities.
Catch stories like these on your own customers.
complead screens your customers against adverse media, sanctions and PEP lists, and re-checks them every day. When a name you hold turns up in the news, it lands in your case queue with the evidence attached.